Sun Pharma gets USFDA nod for Prometh syrup

19 Mar 2010 Evaluate

Drug major Sun Pharma has received approval from the US health regulator for generic version of anti-allergic product Prometh syrup. The United States Food and Drug Administration (FDA) has granted an approval to the company's subsidiary for the syrup.

 

The company's product--Promethazine Hydrochloride and Codeine Phosphate Oral Syrup--is bioequivalent to Prometh. It has annual sales of about $16 million in the US. The medicine is used to treat symptoms caused by common cold, flu, allergies or other breathing problems.

crackcrack

Sun Pharma Inds. Share Price

1724.45 11.25 (0.66%)
20-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1724.45
Dr. Reddys Lab 1280.30
Cipla 1341.45
Zydus Lifesciences 901.00
Lupin 2219.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×